Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-10

Clinical Trial Update: Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dexmedetomidine and meperidine for prevention of shivering after coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Meperidine (Meperidine)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Coronary Artery Disease, Postoperative Shivering | Phase 4 | Status: UNKNOWN